Login to Your Account

Other News To Note

Monday, February 6, 2012

• Retrosense Therapeutics LLC, of Ann Arbor, Mich., received a grant of $250,000 from the Foundation Fighting Blindness to support development of its investigational gene therapy product based on genes from blue-green algae. The foundation may invest additional funds upon achievement of certain milestones in the research. The company anticipates beginning clinical trials in two to four years.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription